CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 11 enrolled
Drug / intervention
Experimental sound coding strategy (FAST) +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02698787
NCT02698787N/ACompleted
CompareCT.gov

Investigation of the FAST Sound Coding Strategy in Newly Implanted Adult Cochlear Implant Recipients

Cochlear·interventional·Posted Mar 4, 2016·Updated Feb 2, 2021

In Brief

A clinical study evaluating Experimental sound coding strategy (FAST) and Commercially available ACE sound coding strategy for Sensorineural Hearing Loss. Completed, enrolled 11 participants across 1 site.

Detailed Summary

The Fundamental Asynchronous Stimulus Timing (FAST) is a novel cochlear implant sound coding strategy. Potential benefits include improved battery life, in addition to improved localization for bilateral patients.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSensorineural Hearing Loss
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedMar 4, 2016
Enrollment StartDec 1, 2015
Primary CompletionNov 19, 2018
TodayJul 2, 2026
Enrollment to primary: 3.0 yearsPosted 10.3 years ago

Interventions

Experimental sound coding strategy (FAST)device

Commercially available Cochlear™ Nucleus® CI24RE with Contour Advance™ Electrode or Cochlear™ Nucleus® CI512 cochlear implant with FAST sound coding strategy using crossover design in newly implanted subjects. Both groups will receive the experimental and control strategy

Commercially available ACE sound coding strategydevice

Commercially available Cochlear™ Nucleus® CI24RE with Contour Advance™ Electrode or Cochlear™ Nucleus® CI512 cochlear implant with FAST sound coding strategy using crossover design in newly implanted subjects. Both groups will receive the experimental and control strategy